PLoS ONE (Jan 2017)

Real-time monitoring of human blood-brain barrier disruption.

  • Vesa Kiviniemi,
  • Vesa Korhonen,
  • Jukka Kortelainen,
  • Seppo Rytky,
  • Tuija Keinänen,
  • Timo Tuovinen,
  • Matti Isokangas,
  • Eila Sonkajärvi,
  • Topi Siniluoto,
  • Juha Nikkinen,
  • Seppo Alahuhta,
  • Osmo Tervonen,
  • Taina Turpeenniemi-Hujanen,
  • Teemu Myllylä,
  • Outi Kuittinen,
  • Juha Voipio

DOI
https://doi.org/10.1371/journal.pone.0174072
Journal volume & issue
Vol. 12, no. 3
p. e0174072

Abstract

Read online

Chemotherapy aided by opening of the blood-brain barrier with intra-arterial infusion of hyperosmolar mannitol improves the outcome in primary central nervous system lymphoma. Proper opening of the blood-brain barrier is crucial for the treatment, yet there are no means available for its real-time monitoring. The intact blood-brain barrier maintains a mV-level electrical potential difference between blood and brain tissue, giving rise to a measurable electrical signal at the scalp. Therefore, we used direct-current electroencephalography (DC-EEG) to characterize the spatiotemporal behavior of scalp-recorded slow electrical signals during blood-brain barrier opening. Nine anesthetized patients receiving chemotherapy were monitored continuously during 47 blood-brain barrier openings induced by carotid or vertebral artery mannitol infusion. Left or right carotid artery mannitol infusion generated a strongly lateralized DC-EEG response that began with a 2 min negative shift of up to 2000 μV followed by a positive shift lasting up to 20 min above the infused carotid artery territory, whereas contralateral responses were of opposite polarity. Vertebral artery mannitol infusion gave rise to a minimally lateralized and more uniformly distributed slow negative response with a posterior-frontal gradient. Simultaneously performed near-infrared spectroscopy detected a multiphasic response beginning with mannitol-bolus induced dilution of blood and ending in a prolonged increase in the oxy/deoxyhemoglobin ratio. The pronounced DC-EEG shifts are readily accounted for by opening and sealing of the blood-brain barrier. These data show that DC-EEG is a promising real-time monitoring tool for blood-brain barrier disruption augmented drug delivery.